<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>American Liver Foundation</title>
	<atom:link href="https://liverfoundation.org/feed/" rel="self" type="application/rss+xml" />
	<link>https://liverfoundation.org</link>
	<description></description>
	<lastBuildDate>Fri, 13 Nov 2026 14:26:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://liverfoundation.org/wp-content/uploads/2022/09/cropped-favicon-32x32.png</url>
	<title>American Liver Foundation</title>
	<link>https://liverfoundation.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Weekly Healthcare Policy Round-Up</title>
		<link>https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-46/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Fri, 13 Nov 2026 14:26:29 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24690</guid>

					<description><![CDATA[<p>A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-46/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong>In this week’s Health Policy Round-Up, ALF shares the most up to date news happening in Washington DC.</strong></p>



<ul class="wp-block-list">
<li>Election Day marked a shift in congressional leadership, with Democrats securing majorities in both the House of Representatives and the Senate for the upcoming 120th Congress. At this time, Democrats gained 42 seats in the House of Representatives, however, the outcomes of 16 races have yet to be confirmed. Additionally, Democrats gained eight seats in the Senate with one race yet to be confirmed. As a new Congress takes shape, ALF looks forward to building relationships with new and returning lawmakers and working across party lines to advance policies that improve health outcomes for liver patients.</li>



<li>Under a new federal law, beginning in January 2027, certain adults enrolled in Medicaid will be required to complete 80 hours per month of work or other qualifying activities to maintain their healthcare coverage. However, people with certain serious or complex medical conditions may qualify for an exemption from these requirements. The Centers for Medicare &amp; Medicaid Services (CMS), the federal agency that oversees Medicaid, issued a rule requiring people seeking a medical exemption to also show that their health condition limits their ability to meet the requirement. Recently, a federal judge in <em>Massachusetts v. Oz</em> struck down this additional requirement. The ruling applies nationwide to states implementing the new Medicaid work requirements. As a result, individuals with a qualifying medical condition will no longer have to demonstrate that their condition limits their ability to work to receive an exemption<strong>.</strong> Earlier this year, ALF expressed concerns to CMS about how the new requirements could affect the liver community and urged CMS to ensure that people with liver disease and those awaiting a liver transplant are considered medically frail and can maintain access to healthcare coverage without meeting the requirement. <a href="https://www.kff.org/quick-insights/court-decision-eases-burden-of-proof-to-qualify-for-medical-frailty-exclusion-to-medicaid-work-requirements/" rel="nofollow noopener" target="_blank">Click here to learn more.</a></li>



<li>On November 9, the Food and Drug Administration announced a new safety warning for GLP-1 medications related to a potential increased risk of a rare but serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). As GLP-1 medications are increasingly used by people with metabolic conditions, including MASH, patients are encouraged to speak with their healthcare provider about any questions or concerns regarding their individual treatment. <a href="https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential" target="_blank" rel="noreferrer noopener nofollow">Read the FDA statement here</a>.</li>



<li>ALF recently released our 2027 Advocacy Priorities Survey, and we want to hear from you! Please complete this short survey to help us identify what matters most to you and what we should focus on in 2027! <a href="https://www.surveymonkey.com/r/3PJQZMF" rel="nofollow noopener" target="_blank">Complete the survey today!</a></li>



<li>Save the date for American Liver Foundation’s <a href="https://liverfoundation.org/events/2026-year-end-advocacy-briefing-celebrating-our-impact-looking-ahead/">Year-End Advocacy Briefing</a> on Wednesday, December 9<sup>th</sup> at 7:00 PM ET/4:00 PM PT. During this virtual briefing, we’ll highlight key advocacy wins from 2026, share updates from across the liver community, and recognize how advocates elevated the voices of liver patients, caregivers, and families. We’ll also look ahead to 2027 legislative and policy priorities and opportunities. We hope you’ll join us as we celebrate our collective impact and prepare for another year of advocacy. <a href="https://liverfoundation.org/events/2026-year-end-advocacy-briefing-celebrating-our-impact-looking-ahead/">Register here</a> for this virtual briefing!</li>
</ul>



<p></p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-46/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Recipients of American Liver Foundation‘s Pilot Research Awards offer Groundbreaking Possibilities</title>
		<link>https://liverfoundation.org/resource-center/blog/recipients-of-american-liver-foundations-pilot-research-awards-offer-groundbreaking-possibilities/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Thu, 05 Nov 2026 13:11:31 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24665</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF)&#160;is thrilled to announce the recipients of its &#160;2026 Pilot Research Awards to support 14 early-career investigators who [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/recipients-of-american-liver-foundations-pilot-research-awards-offer-groundbreaking-possibilities/">Recipients of American Liver Foundation‘s Pilot Research Awards offer Groundbreaking Possibilities</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="http://www.liverfoundation.org/">American Liver Foundation (ALF)</a>&nbsp;is thrilled to announce the recipients of its &nbsp;<a href="https://liverfoundation.org/research/meet-our-awardees/">2026 Pilot Research Awards</a> to support 14 early-career investigators who are providing cutting-edge research in basic, translational and clinical projects. The establishment of the prestigious&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/disease-specific-pilot-research-awards/">Pilot Awards</a> exemplifies ALF’s continued commitment to fund groundbreaking, innovative research that could ultimately lead to therapeutic advances that help us better understand the biology of the liver while also addressing challenges of liver transplantation due to a severe shortage of organs. These exceptional research projects have the potential to significantly advance innovative treatment options that offer solutions for the 100 million Americans affected by some form of liver disease.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALF’s&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/disease-specific-pilot-research-awards/">Pilot Awards</a>&nbsp;will help&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/meet-our-awardees/">fund 14 early-career scientists’</a>&nbsp;highly innovative projects that seek to address important questions related to the following:&nbsp; <a href="https://liverfoundation.org/liver-diseases/treatment/liver-transplant/">Liver transplantation</a> (spanning clinical to experimental research approaches), stem cells, liver regeneration, advanced&nbsp;<em>in vitro</em>&nbsp;human models, and gene/cell-based therapies. All of these junior faculty pilot research projects by recipients of ALF’s Pilot Award have the potential to advance the hepatology field. Each recipient will receive $50,000 in funding for one year. The goal of this award is to provide funding during the pilot phase of research projects that are focused on new areas of investigation, innovative ideas or “high-risk, high reward” projects with the potential to generate breakthrough findings.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “It’s extremely important that ALF funds advanced research projects encompassing a broad range of cutting-edge interventions that help treat, repair or replace the liver in patients with end-stage or complex hepatic conditions,” said David Frank, Chair of ALF’s Board of Directors. “The important findings in these research funded projects can result in obtaining key preliminary data, which enables early career recipients to successfully compete for research awards from the National Institute of Health (NIH) and other national sources to support larger studies in these innovative research areas.”</p>



<p><strong>Recipients of the&nbsp;2026 Pilot Research Awards include:</strong></p>



<ul class="wp-block-list">
<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/lay-teng-ang-phd/">Lay Teng Ang</a>, PhD, Leland Stanford Junior University, for her basic research in Engineering Mature Hepatocytes from Human Pluripotent Stem Cells for Liver Regeneration.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/yuki-bekki-md-phd/">Yuki Bekki,</a> MD, PhD, University of Rochester Medical Center, for his translational research regarding Precision Biomarkers for Liver Transplant Selection and Outcomes in Unresectable Colorectal Liver Metastases.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/shijun-deng-phd/">Shijun Deng</a>, PhD, Harvard T. H. Chan School of Public Health, for his basic research in Defining Lipoprotein Endpoints of AAV-NFE2L1 Gene Therapy for MASH-Associated Atherogenic Dyslipidemia.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/benjamin-dulken-md-phd/">Ben Dulken</a>, MD, PhD, University of Washington, for his translational research on Spatial Analysis of the Rejection Microenvironment and Identification of Novel Tissue Markers for Rejection.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/jason-eng-md-phd/">Jason Eng</a>, MD, PhD, Ohio State University Wexner Medical Center, for his translational research on Targeting CD38 to Enhance Liver Regeneration.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/xiaodong-ge-md-phd/">Xiaodong Ge</a>, MD, PhD, University of Illinois Chicago, for his basic research on the Role of SPP1 in the Pathogenesis of PSC.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/leigh-goedeke-bs-phd/">Leigh Goedeke</a>, BS, PhD, Icahn School of Medicine Mount Sinai, for her basic research on Targeting hepatocyte-macrophage crosstalk to treat chronic liver disease.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/chris-hsiung-md-phd/">Chris Hsiung</a>, MD, PhD, University of California, San Francisco, for his basic research on the Discovery of pro-fibrogenic enhancers in hepatic stellate cells using high-throughput combinatorial CRISPR perturbations.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/jain-jeong-phd/">Jain Jeong,</a> PhD, Yale University, for his basic research on the Hepatic Lymphatic Vessels in Liver Regeneration: Mechanisms and Therapeutic Potential.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/duc-huy-nguyen-phd/">Duc-Huy Nguyen,</a> PhD, University of Wisconsin, for his basic research on A Human Liver-on-a-Chip Platform to Decode Liver Sinusoidal Endothelial Cell Identity.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/tianliang-sun-phd/">Tianliang Sun</a>, PhD, Icahn School of Medicine at Mount Sinai, for his basic research on Injury and Recovery Associated Cholangiocyte States: Lineage Origins, Fate Transitions, and Functional Roles in Chronic Liver Disease.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/shuang-sammi-wang-phd/">Shuang (Sammi) Wang</a>, PhD, Icahn School of Medicine at Mount Sinai, for her basic research on Restoring Midzonal Hepatocyte Identity to Improve Regenerative Capacity in Chronic Liver Disease.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/xiaobo-wang-phd/">Xiaobo Wang</a>, PhD, Columbia University Irving Medical Center for his translational research on Deciphering Hepatocyte–Macrophage–Stellate Cell Crosstalk in MASH Fibrosis Using Human Organoids and iPSCs.</li>



<li><a href="https://liverfoundation.org/research/disease-specific-pilot-research-awards/yankai-wen-phd/">Yankai Wen</a>, PhD, The University of Texas Health Science Center, for his basic research on The role of macrophage-derived hypoxia-inducible factor 2 alpha in liver regeneration.</li>
</ul>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “The main goal of ALF Pilot Awards this year is to address key outstanding questions that have the potential to generate significant findings in research areas with fundamental knowledge gaps such as liver regeneration and stem cells, and to lead to therapeutic advances in liver transplantation and cell therapy,” said Helene Jordan, PhD, National Senior Director, Research Program Management, ALF. “This highly innovative research helps us find new and emerging strategies to tackle the severe shortage of available liver organs, which is extremely important because liver disease is a public health crisis impacting far too many people.”</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Since 1980, ALF’s research awards program has provided more than&nbsp;<a href="https://liverfoundation.org/research/research-program-overview/">$30 million in research funding</a>. More than 935 qualified scientists and physicians have pursued research careers in liver biology, disease and treatment because they received these grants early in their careers.</p>



<p>To learn more about ALF’s research award program, please visit&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program">liverfoundation.org/research</a>.&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/join-our-research-awards-mail-list/">Join the mailing list</a>&nbsp;to receive updates on ALF Research Awards.</p>



<p><strong><u>About the American Liver Foundation</u></strong></p>



<p>American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research, and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. Celebrating 50 years of impact, leading the next 50 years forward. For more information, please visit&nbsp;<a href="http://www.liverfoundation.org/">www.liverfoundation.org</a>&nbsp;or call: 1.800.GO.LIVER (800-465-4837).</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/recipients-of-american-liver-foundations-pilot-research-awards-offer-groundbreaking-possibilities/">Recipients of American Liver Foundation‘s Pilot Research Awards offer Groundbreaking Possibilities</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Michael Karin, PhD, receives ALF&#039;s 2026 Distinguished Scientific Achievement Award</title>
		<link>https://liverfoundation.org/resource-center/blog/michael-karin-phd-receives-alfs-2026-distinguished-scientific-achievement-award/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Wed, 04 Nov 2026 13:05:37 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24657</guid>

					<description><![CDATA[<p>ALF announces Michael Karin, PhD, as the recipient of its prestigious 2026 Distinguished Scientific Achievement Award, recognizing his nearly five decades of research on the biological pathways that connect inflammation, metabolic disease and liver cancer.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/michael-karin-phd-receives-alfs-2026-distinguished-scientific-achievement-award/">Michael Karin, PhD, receives ALF&#039;s 2026 Distinguished Scientific Achievement Award</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="text--l text--primary"><em><em>Award recognizes Karin’s nearly five decades of groundbreaking discoveries in understanding liver biology and inflammation</em></em></p>



<p><a href="https://liverfoundation.org">American Liver Foundation (ALF</a>) is proud to announce that Michael Karin, PhD, is the recipient of its prestigious <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">2026 Distinguished Scientific Achievement Award (DSAA)</a>. Dr. Karin is the Director and Professor of the Center for Metabolic and Liver Diseases at the Sanford Burnham Prebys Medical Discovery Institute. ALF’s DSAA was presented to Dr. Karin at a VIP reception that preceded <a href="https://alfgala.org/national-legacy-gala/" rel="nofollow noopener" target="_blank">ALF’s 50<sup>th</sup> Anniversary National Legacy Gala</a> held in NYC on Wednesday, Oct. 28. This esteemed award recognizes Karin’s longstanding contributions spanning nearly five decades of research focusing on the biological pathways that connect inflammation, metabolic disease and liver cancer. His research has helped clarify how inflammatory signaling and metabolic stress can drive disease.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “We are so honored to recognize Dr. Karin for his trailblazing research discoveries that have helped illuminate the connections between inflammation, metabolism, and liver disease—connections that open potential &nbsp;paths to preventing and treating steatohepatitis and other metabolic conditions,” said Lorraine Stiehl, Chief Executive Officer of American Liver Foundation. “His work reminds us that progress for people living with liver disease begins with the courage to ask fundamental questions and the persistence to follow the evidence. We are proud to acknowledge a scientist whose cutting-edge discoveries continue to inspire the field.”</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr. Karin’s unprecedented research discoveries, scientific leadership and commitment to mentorship and collaboration have shaped the field of hepatology. At Sanford Burnham Prebys, the Karin lab is currently focused on three research areas – inflammation biology and how it is impacted by an individual’s metabolic and nutritional state; how immune system stimulation and metabolic disease such as type 2 diabetes cooperate to drive the development of <a href="https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/">metabolic dysfunction associated steatotic liver disease</a> (MASLD); and the role of inflammation and aberrant metabolism in cancer (including pancreatic, liver and gastrointestinal cancers). His achievements have laid the foundation for numerous therapeutic strategies currently in development and have directly influenced how the scientific community understands the interplay between inflammatory and immune signaling, metabolism, and how liver cancer develops. During his time at UC San Diego, Karin explored the role of immune responses and cellular stress in chronic inflammation and cancer and also demonstrated that immune checkpoint inhibitors can be used to inhibit the progression of hepatocellular carcinoma. These discoveries underscore why fundamental research matters to the future of liver health.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “I’m truly honored to receive the prestigious DSAA from American Liver Foundation,” said Dr. Michael Karin, Director and Professor of the Center for Metabolic and Liver Diseases. “Future development of therapies for those living with MASLD and metabolic dysfunction-associated steatohepatitis (MASH) are on the horizon, and I’m proud that the Karin lab was actively involved in the research discoveries that will make those therapies a reality for the 100 million Americans living with metabolic diseases and liver conditions.”</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Distinguished Scientific Achievement Award is presented annually to a basic researcher or physician scientist with a longstanding commitment to scientific discovery who has made major contributions to basic liver research or its application in the prevention, diagnosis, or treatment of liver disease. The 2025 recipient of the Distinguished Scientific Achievement Award was <a href="https://liverfoundation.org/resource-center/blog/yale-school-of-medicines-dr-gerald-i-shulman-named-2025-recipient-of-american-liver-foundations-distinguished-scientific-achievement-award/">Gerald I. Shulman, MD, PhD</a> of Yale School of Medicine.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr. Karin received his PhD in Molecular Biology from UCLA in 1979 and conducted postdoctoral research at the Fox Chase Cancer Center from 1979 to 1983. He served as an Assistant Professor in the Department of Microbiology at USC School of Medicine in 1983. He went on to join the Department of Pharmacology at UC San Diego School of Medicine in 1985 where he rose through the ranks to become the Distinguished Professor of Pharmacology and Pathology and served on the faculty until July 2025. That same year, Karin joined the Sanford Burnham Prebys Medical Research Institute as its Center Director for Metabolic and Liver Disease where he remains today. Throughout Karin’s unwavering dedication to uncover the molecular roots of liver disease, his academic history of investigating stress and inflammation, and his overall work has not only deepened our biological understanding of these diseases but also offers true hope for millions impacted by liver diseases.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In addition to the prestigious <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">DSAA</a>, <a href="https://liverfoundation.org/">American Liver Foundation</a> also offers a <a href="https://liverfoundation.org/research/research-program-overview/">research awards program</a> in four categories, <a href="https://liverfoundation.org/medical-professionals/research-awards-program/liver-scholar-award/">Liver Scholar Award</a>, <a href="https://liverfoundation.org/medical-professionals/research-awards-program/postdoctoral-fellowships/">Postdoctoral Research Fellowship Award</a>, <a href="https://liverfoundation.org/medical-professionals/research-awards-program/disease-specific-pilot-research-awards/">Pilot Award</a>, and <a href="https://liverfoundation.org/medical-professionals/research-awards-program/travel-awards/">Travel Award</a> to provide the necessary funding to help advance research in liver biology and disease. Since 1980, ALF’s research awards program has provided more than $30 million in research funding. More than 935 qualified scientists and physicians have pursued research careers in liver biology, disease and treatment because they received these grants early in their careers. Learn more at <a href="https://liverfoundation.org/medical-professionals/research-awards-program">Research Awards Program - American Liver Foundation</a>.</p>



<p>For more information about ALF, please visit <a href="http://www.liverfoundation.org">www.liverfoundation.org</a>. If you have any questions or concerns regarding liver disease, please call our FREE helpline at 1-800-Go-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.</p>



<p><strong><u>About the American Liver Foundation</u></strong></p>



<p>American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research, and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. Celebrating 50 years of impact, leading the next 50 years forward. For more information, please visit&nbsp;<a href="http://www.liverfoundation.org/">www.liverfoundation.org</a>&nbsp;or call: 1.800.GO.LIVER (800-465-4837).</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/michael-karin-phd-receives-alfs-2026-distinguished-scientific-achievement-award/">Michael Karin, PhD, receives ALF&#039;s 2026 Distinguished Scientific Achievement Award</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Marathon Runners Take to the Big Apple to Raise Awareness of Liver Disease</title>
		<link>https://liverfoundation.org/resource-center/blog/marathon-runners-take-to-the-big-apple-to-raise-awareness-of-liver-disease-4/</link>
		
		<dc:creator><![CDATA[William Rivera]]></dc:creator>
		<pubDate>Fri, 30 Oct 2026 17:42:16 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24629</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF) is proud to once again be a member of the TCS New York City Marathon Charity Program, for the 2026 race, which takes place on Sunday, November 1. Runners will complete 26.2 miles through New York City’s five boroughs.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/marathon-runners-take-to-the-big-apple-to-raise-awareness-of-liver-disease-4/">Marathon Runners Take to the Big Apple to Raise Awareness of Liver Disease</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="text--l text--primary">2026 TCS New York City Marathon is Sunday, November 1st</p>



<p><a href="https://liverlifewalk.org/" rel="nofollow noopener" target="_blank">American Liver Foundation (ALF</a>) is proud to once again be a member of the <a href="https://liverlifechallenge.org/tcsnycmarathon/" rel="nofollow noopener" target="_blank">TCS New York City Marathon Charity Program,</a> for the 2026 race, which takes place on Sunday, November 1. Runners will complete 26.2 miles through New York City’s five boroughs.</p>



<p>“ALF is grateful to once again be an official charity partner of the 2026 TCS New York City Marathon,” said Lorraine Stiehl, Chief Executive Officer, American Liver Foundation. “We have an amazing group of runners who continue to raise awareness and funds for the nearly 100 million people in America affected by some form of liver disease.”</p>



<p>All funds raised go towards ALF’s mission to support those affected by <a href="https://liverfoundation.org/liver-diseases/">liver disease</a>. The ALF marathon team is made up of runners with varying levels of experience from novice to advanced, most of whom have a connection to liver disease.</p>



<p><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#mattluneburg" rel="nofollow noopener" target="_blank">Matthew Luneburg</a> is the 2026 New York City Marathon <a href="https://liverlifechallenge.org/" rel="nofollow noopener" target="_blank">Liver Life Challenge</a> Team Captain that runs in honor of his father who is celebrating 14 years cancer-free from liver cancer. After a yearlong battle in Memphis, Tennessee that included many 2 a.m. ambulance calls and lots of tears and scary days and nights, Matthew’s dad received the gift of life – a liver transplant! “Too many kids are waiting up for their mom and dad to come home. The American Liver Foundation served as a beacon of hope when that kid was me. I’ll be running those 26.2 miles for them, this city, and (of course) my dad – the Spirit of New York,” said Matthew Luneburg.</p>



<p><strong>Additional runners on ALF’s 30-member team include:&nbsp; </strong><strong></strong></p>



<ul class="wp-block-list">
<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#jennie" rel="nofollow noopener" target="_blank">Jennie Cataldo</a>: She’s running for the first time in the NYC Marathon on Team ALF. As an Outreach Program Manager for Lahey Hospital Clinic’s Division of Transplantation and Hepatobiliary Disease, Jennie understands what transplant patients go through and just wants to raise awareness of liver disease and the importance of liver transplantation.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#katedorfman" rel="nofollow noopener" target="_blank">Kathleen Dorfman</a>: She’s running for the first time in the NYC Marathon in honor of her nephew who was diagnosed with <a href="https://liverfoundation.org/liver-diseases/pediatric-liver-information-center/pediatric-liver-disease/biliary-atresia/">Biliary Atresia</a> and received a liver transplant at 10 months old.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#meganrunsforliver" rel="nofollow noopener" target="_blank">Megan Dunn</a>: Running for the first time in the NYC Marathon, Megan has been a liver transplant and living donor social worker at Beth Israel Deaconess Medical Center Transplant Institute for the last four years. She wants to support her patients by raising funds for ALF that provides essential support to those with liver disease.   </li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#p2p/315035" rel="nofollow noopener" target="_blank">Hannah Fleming</a>: She is running in her first marathon with Team ALF to raise awareness about liver disease. Diagnosed with <a href="https://liverfoundation.org/liver-diseases/pediatric-liver-information-center/pediatric-liver-disease/biliary-atresia/">Biliary Atresia</a>, a rare liver disease, she received a life-saving liver transplant at eight months old. Today, she’s a liver transplant operating room nurse who finds it incredible that she gets to work with transplant patients.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#kelseakim" rel="nofollow noopener" target="_blank">Kelsea Kim</a>: Running her first NYC Marathon with Team ALF, Kelsea was diagnosed at 21 years old with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/autoimmune-hepatitis-aih/">Autoimmune Hepatitis (AIH</a>) and eventually <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis (PSC)</a> and ulcerative colitis (UC). She runs for those living with liver disease as well as for herself because it grounds her and lets her know her body is strong and capable.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#p2p/314693" rel="nofollow noopener" target="_blank">Sidney Monday and Steve Nugent</a>: They are both running for the first time in the NYC Marathon on Team ALF. Steve, a two-time liver recipient with an autoimmune liver disease, runs in honor of his amazing donors and raises awareness for organ donation. Steve has run the Boston Marathon on ALF’s team for three years.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#p2p/315539" rel="nofollow noopener" target="_blank">Saylor Smith</a>: She’s running for the first time with Team ALF in honor of her mother who lost her battle with <a href="https://liverfoundation.org/liver-diseases/cancer/bile-duct-cancer-cholangiocarcinoma/">cholangiocarcinoma</a> after being diagnosed at 33 years old.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#p2p/314594" rel="nofollow noopener" target="_blank">Keith Tully</a>: He’s running in the NYC marathon for the first time with Team ALF, and he has run in the Boston Marathon for 13 years with Team ALF. Tully, diagnosed with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis</a>, received a lifesaving transplant from a living donor.</li>



<li><a href="https://liverlifechallenge.org/tcsnycmarathon/support/#Davidweston" rel="nofollow noopener" target="_blank">David Weston</a>: Running in the NYC Marathon for the 3<sup>rd</sup> year on Team ALF and has run for two years in the NYC Half Marathon with Team ALF. He runs in honor of his father who exhibited so much strength in his fight against a liver disease that eventually took his life. David is inspired by his father’s strength throughout his journey and has been honoring his memory for over 20 years by running in marathons.</li>
</ul>



<p>Learn more about <a href="https://liverlifechallenge.org/tcsnycmarathon/event-details/" rel="nofollow noopener" target="_blank">ALF’s 2026 TCS New York City Marathon team</a> and support their 26.2 mile run at <a href="https://liverlifechallenge.org/tcsnycmarathon/" rel="nofollow noopener" target="_blank">https://liverlifechallenge.org/tcsnycmarathon/</a>.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/marathon-runners-take-to-the-big-apple-to-raise-awareness-of-liver-disease-4/">Marathon Runners Take to the Big Apple to Raise Awareness of Liver Disease</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Weekly Healthcare Policy Round-Up</title>
		<link>https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-45/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Fri, 30 Oct 2026 13:14:11 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24620</guid>

					<description><![CDATA[<p>A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-45/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong>In this week’s Health Policy Round-Up, ALF shares the most up to date news happening in Washington DC.</strong></p>



<ul class="wp-block-list">
<li>During National Liver Awareness Month, American Liver Foundation hosted the MASH: Empower and Educate Summit in Chicago Illinois. ALF brought together 30 liver patients to raise awareness about MASH. This two-day event empowered patients and caregivers through robust education, storytelling, and media training. ALF was honored to bring together so many people for an engaging weekend! Read our <a href="https://liverfoundation.org/resource-center/blog/american-liver-foundation-hosts-mash-empower-and-educate-summit/">press release</a> to learn more about the event.</li>



<li>National Liver Awareness Month may be coming to an end, but there’s still time to speak up for liver health. Join us in urging lawmakers to prioritize liver health and support policies that improve the lives of those affected by liver disease. Take action <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/take-action/?vvsrc=%2fCampaigns%2f133344%2fRespond">here</a>!</li>



<li>American Liver Foundation celebrates the Food and Drug Administration’s (FDA) approval of Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, for the treatment of chronic hepatitis B virus (HBV) infection! Hibsago is approved for eligible adults who have been receiving HBV antiviral therapy for at least six months, have suppressed levels of HBV in their blood, and have hepatitis B surface antigen levels of 3,000 IU/mL or less. This approval represents an important advancement for people living with chronic hepatitis B and underscores the continued progress being made toward improving treatment options and long-term outcomes for individuals affected by liver disease. Learn more <a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-chronic-hepatitis-b-treatment" rel="nofollow noopener" target="_blank">here</a>!</li>



<li>Election Day is Tuesday, November 3rd. Make your voting plan today, your voice matters!Explore ALF’s Election Center <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/election-center/">here</a>.</li>



<li>The Affordable Care Act open enrollment period begins Sunday November 1st and remains open through January 15, 2027. If you or someone you know is looking for health insurance through the Marketplace, visit HealthCare.gov to learn more about available plans and find the coverage that’s right for you.</li>
</ul>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-45/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Pro Football Hall of Famer Dan Marino Keynoted American Liver Foundation (ALF) Gala</title>
		<link>https://liverfoundation.org/resource-center/blog/pro-football-hall-of-famer-dan-marino-keynoted-american-liver-foundation-alf-gala/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Thu, 29 Oct 2026 14:38:45 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24612</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF) is pleased to announce that Pro Football Hall of Famer Dan Marino was the keynote speaker at its 50th Anniversary National Legacy Gala on Wednesday, Oct. 28 at Gotham Hall in New York City.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/pro-football-hall-of-famer-dan-marino-keynoted-american-liver-foundation-alf-gala/">Pro Football Hall of Famer Dan Marino Keynoted American Liver Foundation (ALF) Gala</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="text--l text--primary"><em>ALF Celebrates 50<sup>th</sup> Anniversary National Legacy Gala Honoring Leaders and Organizations in Liver Disease and Liver Transplantation</em></p>



<p><a href="https://liverfoundation.org">American Liver Foundation (ALF)</a> is pleased to announce that Pro Football Hall of Famer Dan Marino was the keynote speaker at its <a href="https://alfgala.org/national-legacy-gala/" rel="nofollow noopener" target="_blank">50th Anniversary National Legacy Gala</a> on Wednesday, Oct. 28 at Gotham Hall in New York City. As guest of honor, Marino shared his lived experience with <a href="https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-steatohepatitis-nash/">Metabolic Dysfunction-Associated Steatohepatitis (MASH)</a> and the importance of consistency in healthy eating and well-rounded fitness routines as well as maintaining a positive attitude with the diagnosis. He acknowledged MASH as a silent killer and stressed the importance of getting tested and learning as much as possible about the disease. Marino’s message embodied what it means to take charge of your liver health, and his presence helped ALF commemorate five decades of supporting liver patients and their families while working with top-tier medical professionals and leading organizations in liver disease and liver transplantation.  </p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “We were deeply honored and grateful to Dan Marino for his keynote address at ALF’s 50<sup>th</sup> National Legacy Gala,” said Lorraine Stiehl, CEO of American Liver Foundation and a caregiver of a transplant recipient. “His presence made ALF’s Gala even more meaningful and added a special significance to this landmark celebration that brought together supporters, partners, and leaders in the field of liver disease to honor ALF’s legacy while celebrating our past, present, and future. We were so appreciative for his support as we celebrated this important milestone together.”</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ALF celebrated its legacy through tributes to multiple awardees – <a href="https://alfgala.org/national-legacy-gala/support/#p2p/319063" rel="nofollow noopener" target="_blank">UPMC</a> (Transplant Legacy Award), <a href="https://alfgala.org/national-legacy-gala/support/#AstraZeneca" rel="nofollow noopener" target="_blank">AstraZeneca</a> (Patient Impact Award), <a href="https://alfgala.org/national-legacy-gala/support/#ArunSanyal" rel="nofollow noopener" target="_blank">Arun Sanyal, MD</a>, of Virginia Commonwealth University (Leadership Award), and <a href="https://alfgala.org/national-legacy-gala/support/#Novo" rel="nofollow noopener" target="_blank">NOVO</a> (Leadership Innovation Award). In addition, ALF presented its Leadership Award for Public Service to <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Frank A. Anania, MD,</a> of the Food and Drug Administration (FDA) and <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Jay H. Hoofnagle, MD</a>, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). ALF awarded its <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">Distinguished Scientific Achievement Award (DSAA)</a> to <a href="https://sbpdiscovery.org/scientists/michael-karin-phd/" rel="nofollow noopener" target="_blank">Director and Professor Michael Karin, PhD</a>, of the Center for Metabolic and Liver Diseases at Sanford Burnham Prebys Medical Discovery Institute. Each recipient represented a shared commitment to better the lives of liver patients and highlighted ALF’s past, present and future accomplishments on behalf of the 100 million Americans living with some form of liver disease.</p>



<p>ALF also honored board member, <a href="https://liverfoundation.org/about-alf/people/peter-cullen/">Peter Cullen</a>, an entrepreneur and former media executive for Disney and ABC, with the inaugural <a href="https://liverfoundation.org/resource-center/blog/alf-mourns-the-passing-of-former-board-member-michael-kerr/">Michael Kerr</a> Volunteer of the Year Award, which recognizes outstanding volunteer contributions at ALF. Peter, diagnosed with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis (PSC)</a>, required a lifesaving <a href="https://liverfoundation.org/liver-diseases/treatment/liver-transplant/">liver transplant</a> and his brother became the <a href="https://liverfoundation.org/liver-diseases/treatment/organ-donation/">living donor</a>, but the liver failed to thrive. Peter endured more than a decade of surgeries and medical interventions. After developing recurrent PSC, he received a second liver transplant from a deceased donor in 2016. Peter played an instrumental role in ALF’s strategic rebranding and&nbsp; led the creation of ALF’s first character and children’s book, <a href="https://bilithebrave.org/" rel="nofollow noopener" target="_blank">Bili the Brave™</a>, that was developed for children and families affected by <a href="https://liverfoundation.org/liver-diseases/pediatric-liver-information-center/pediatric-liver-disease/biliary-atresia/">biliary atresia</a>. Michael Kerr’s widow, Susie, and his son, Joshua, as well as his granddaughter, Jenny, presented ALF’s distinguished award to Mr. Cullen.</p>



<p><strong>The 2026 Award Recipients included: &nbsp;</strong></p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#p2p/319063" rel="nofollow noopener" target="_blank"><strong>Transplant Legacy Award, UPMC</strong></a><strong><u></u></strong></p>



<p>With nearly 30 years of demonstrated commitment to a shared mission of offering hope and healing to liver patients, <a href="https://www.upmc.com/?utm_mrid=mrid0689&amp;utm_adgroup=85731913810&amp;utm_advertiserid=8542765693&amp;gclid=65eb1157943512c2c0927b94738afdf7&amp;gclsrc=3p.ds&amp;msclkid=65eb1157943512c2c0927b94738afdf7&amp;utm_source=bing&amp;utm_medium=cpc&amp;utm_campaign=System%20-%20Branded%20-%20National&amp;utm_term=www.upmc.com&amp;utm_content=UPMC%20URLs%20-%20Exact" rel="nofollow noopener" target="_blank">UPMC</a> continues to demonstrate both exemplary leadership and continued generosity to ALF initiatives. As the nation’s leading transplant center conducting the highest number of living donor liver transplants in the United States, UMPC’s longstanding support of ALF has helped drive critical patient education, advocacy, research, and support services to many liver patients.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#AstraZeneca" rel="nofollow noopener" target="_blank"><strong>Patient Impact Award, AstraZeneca</strong></a><strong></strong></p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#AstraZeneca" rel="nofollow noopener" target="_blank">AstraZeneca</a> was recognized for its patient-centered efforts to help transform liver disease and liver cancer care through science, partnerships, advocacy and groundbreaking advances in medicine. As a founding partner of ALF’s transformative <a href="https://thinkliverthinklife.org/" rel="nofollow noopener" target="_blank"><em>Think Liver Think Life</em></a> public health campaign, the company has played an important role in expanding screening, education, and support resources in diverse communities across the country.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#ArunSanyal" rel="nofollow noopener" target="_blank"><strong>Leadership Award, Dr. Arun Sanyal</strong></a><strong><u></u></strong></p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#ArunSanyal" rel="nofollow noopener" target="_blank">Arun J. Sanyal, MD</a>, is one of the world’s leading experts in liver disease research and helped shaped the global approach to understanding and treating <a href="https://us-east-2.protection.sophos.com?d=urldefense.com&amp;u=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&amp;i=NjZlOWJlMDlhZWY4NTUwZTY2MmE0Njg2&amp;t=YTdhV3dFYnVoK3VQWm5EYXdGR1VBaCtWRlAzRFlxRTloUGV1aXhsV2hGZz0=&amp;h=323f935e88b6417aba6a5a1c9c1cc6b3&amp;s=AVNPUEhUT0NFTkNSWVBUSVbOnd89rL3xJVz9Op9bY9T44xZTl_I9YxllAWGxbqSJcQ" target="_blank" rel="noreferrer noopener nofollow">metabolic dysfunction associated steatotic liver disease (MASLD)</a> and <a href="https://us-east-2.protection.sophos.com?d=urldefense.com&amp;u=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&amp;i=NjZlOWJlMDlhZWY4NTUwZTY2MmE0Njg2&amp;t=dE1YdnRlMlpkOGJoMW1jMGhIVzNKUU4xcGlBMFl2WUQ0NUVrS0FUeWU5cz0=&amp;h=323f935e88b6417aba6a5a1c9c1cc6b3&amp;s=AVNPUEhUT0NFTkNSWVBUSVbOnd89rL3xJVz9Op9bY9T44xZTl_I9YxllAWGxbqSJcQ" target="_blank" rel="noreferrer noopener nofollow">metabolic dysfunction associated steatohepatitis (MASH)</a>. Dr. Sanyal is the Professor Director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health School of Medicine Internal Medicine at Virginia Commonwealth University.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#Novo" rel="nofollow noopener" target="_blank"><strong>Leadership Innovation Award, NOVO</strong></a><strong></strong></p>



<p>For over a century, <a href="https://alfgala.org/national-legacy-gala/support/#Novo" rel="nofollow noopener" target="_blank">NOVO</a> has specialized in discovering, developing and delivering protein and peptide-based treatments for serious chronic diseases, primarily diabetes and metabolic care, and was honored for its innovation in metabolic health and liver disease. Building upon decades of expertise in diabetes and obesity, the organization is advancing research in MASH.</p>



<p><strong><a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Leadership Award for Public Service, Dr. Frank A. Anania and Dr. Jay H. Hoofnagle</a></strong></p>



<ul class="wp-block-list">
<li><a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Frank A. Anania, MD, FAASLD</a>, is the Director of the Division of Hepatology and Nutrition at the U.S. Food and Drug Administration (FDA) who oversees the safety, efficacy, and regulatory review of clinical trials and novel drug pipelines. Dr. Anania was presented with the <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">2026 ALF Leadership Award for Public Service</a>.</li>



<li><a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Jay H. Hoofnagle, MD, FAASLD</a>, Former Director of the Liver Diseases Research Branch of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), also received the <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">2026 ALF Leadership Award for Public Service</a> that evening. Although he retired this year, his career spans more than 50 years in liver disease research.</li>
</ul>



<p><a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/"><strong>Distinguished Scientific Achievement Award, Dr. Michael Karin</strong></a></p>



<p><a href="https://sbpdiscovery.org/scientists/michael-karin-phd/" rel="nofollow noopener" target="_blank">Michael Karin, PhD.,</a> is the Director and Professor of the Center for Metabolic and Liver Diseases at Sanford Burnham Prebys Medical Research Institute. Dr. Karin was presented with the foundation’s <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">2026 Distinguished Scientific Achievement Award</a> at a VIP reception that preceded the Gala.</p>



<p>The evening also featured <a href="https://alfgala.org/national-legacy-gala/support/#TommyNolan" rel="nofollow noopener" target="_blank">ALF’s LIVEr Champion Tommy Nolan</a> who lived with liver disease for years while being a U.S. Navy veteran serving from 1978 to 1982 and a NYPD sergeant from 1988 to 2006. After a routine doctor’s appointment revealed elevated liver enzymes, Tommy was diagnosis with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis (PSC</a><strong>)</strong>, a rare autoimmune liver disease with no cure that had progressed to liver cirrhosis. In 2023, he had a complex liver transplant that saved his life.</p>



<p>ALF extends its deepest gratitude to the 2026 National Legacy Gala Chair, <a href="https://alfgala.org/national-legacy-gala/support/#SamanthaKellner" rel="nofollow noopener" target="_blank">Samantha Kellner</a>, whose personal connection to ALF’s mission was shaped by the birth of her second child Raphael, diagnosed with a rare liver disease called <a href="https://liverfoundation.org/liver-diseases/pediatric-liver-information-center/pediatric-liver-disease/biliary-atresia/">biliary atresia</a> as an infant and given a lifesaving transplant within eight weeks of his birth. Inspired by their family’s journey, Samantha and her family launched the Kellner Pediatric Liver Foundation (KPLF) and celebrated their 20<sup>th</sup> Anniversary as dedicated advocates for children and families affected by liver disease.</p>



<p>The evening included a unique silent auction, a three-course plated dinner, an exciting live auction, and a memorable awards ceremony. Funds raised through the 50<sup>th</sup> Anniversary National Legacy Gala benefit the 100 million Americans affected by liver disease through <a href="https://liverfoundation.org/resource-center/">resources</a>,&nbsp;<a href="https://liverfoundation.org/about-your-liver/">education</a>&nbsp;and&nbsp;<a href="https://liverfoundation.org/resource-center/help-center/">support services</a>&nbsp;and to help&nbsp; advance&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/research-program-overview/">research&nbsp;</a>and our patient&nbsp;<a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/">advocacy </a>efforts on Capitol Hill.&nbsp;</p>



<p>For more information about ALF, please visit <a href="http://www.liverfoundation.org">www.liverfoundation.org</a>. If you have any questions or concerns regarding <a href="https://liverfoundation.org/liver-diseases/">liver diseases</a>, please call our FREE helpline at 1-800-GO-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.</p>



<p><strong><u>About the American Liver Foundation</u></strong></p>



<p>American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research, and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. Celebrating 50 years of impact, leading the next 50 years forward. For more information, please visit&nbsp;<a href="http://www.liverfoundation.org/">www.liverfoundation.org</a>&nbsp;or call: 1.800.GO.LIVER (800-465-4837).</p>



<p></p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/pro-football-hall-of-famer-dan-marino-keynoted-american-liver-foundation-alf-gala/">Pro Football Hall of Famer Dan Marino Keynoted American Liver Foundation (ALF) Gala</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>American Liver Foundation Hosts MASH: Empower and Educate Summit</title>
		<link>https://liverfoundation.org/resource-center/blog/american-liver-foundation-hosts-mash-empower-and-educate-summit/</link>
		
		<dc:creator><![CDATA[William Rivera]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 21:18:24 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24589</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF) hosted its MASH: Empower and Educate Summit on Friday, Oct. 16 and Saturday, Oct. 17 at the Sheraton Grand Chicago Hotel, bringing together 30 patients from across the country who live with metabolic dysfunction-associated steatohepatitis (MASH) or metabolic dysfunction-associated steatotic liver disease (MASLD). </p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/american-liver-foundation-hosts-mash-empower-and-educate-summit/">American Liver Foundation Hosts MASH: Empower and Educate Summit</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="text--l text--primary">Patients with MASLD/MASH from Across the U.S. Gathered in Chicago for Educational Workshops and Events</p>



<p><a href="https://livingfoundation.org" rel="nofollow noopener" target="_blank">American Liver Foundation (ALF)</a> hosted its <strong>MASH: Empower and Educate Summit</strong> on Friday, Oct. 16 and Saturday, Oct. 17 at the Sheraton Grand Chicago Hotel, bringing together 30 patients from across the country who live with <a href="https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-steatohepatitis-nash/">metabolic dysfunction-associated steatohepatitis (MASH)</a> or <a href="https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/">metabolic dysfunction-associated steatotic liver disease (MASLD).</a> The goal of ALF’s Summit was to educate patients on their conditions and the latest in treatments and research, share information on health and wellness, and provide media training to help patients amplify their voices with media outlets throughout the country in an effort to raise national awareness of liver disease. &nbsp;</p>



<p>“Through initiatives like the MASH: Empower and Educate Summit, ALF continues to support caregivers and patient advocates living with MASH or MASLD who all gained vital information at the Summit, enjoyed connecting with other patients and hearing their lived experiences, and learned how to raise awareness about liver disease by sharing their own stories clearly and quickly,” said Lorraine Stiehl, CEO of American Liver Foundation and a caregiver of a transplant recipient. “Participates enjoyed two full days of presentations and panel discussions led by medical professionals, nutritionists, health care journalists, and media training executives who provided valuable insights and conveyed relevant information that helped the patients gain a much better understanding of their conditions, how to manage those conditions and how to share their personal stories with the press.”</p>



<p>Gastroenterologist, Transplant Hepatologist and Assistant Professor Christopher Kasia, MD, of the University of Chicago, presented, <strong>The Latest in Liver Care: From Research to Treatment</strong>. Transplant Hepatologist Richard Green, MD, of Northwestern Medicine, joined Dr. Kasia as both presenters shared how patients can take charge of their liver health. They presented key findings regarding liver care and liver transplantation and also shared the newly approved liver disease therapies. Andres Castillo, APRN, Nurse Practitioner in Hepatology at Northwestern Medicine presented, <strong>Living Well with MASH: Small Changes, Big Impact</strong> and shared great exercises at every level of someone’s fitness journey from beginners to fitness enthusiasts. Castillo emphasized the importance of gradually incorporating various fitness routines into your fitness journey.</p>



<p>Registered Dietitian Nutritionist Jamie Simko, MS, LD, of Indiana University Health University Hospital presented, <strong>The Liver-Friendly Kitchen: Food, Flavor, and Nutrition. </strong>Her session focused on liver healthy food, how to flavor your food without using sodium, and also overall nutritional advice for patients withadvanced liver disease and those who are pre-and post-liver transplantation. Clinical Psychologist Anahli Patel, Psyd, HSPP, of Indiana University Health University Hospital presented, <strong>Destigmatizing MASH</strong> where she helped patients navigate the emotional and psychological challenges associated with chronic health conditions like MASH. Her session helped provide a better understanding of the stigma of MASH and how to challenge common misconceptions and reframe the narrative regarding MASH. A final panel presentation focused on practical strategies for managing MASH and related conditions such as diabetes and included MASH patient Dr. Shawanna James-Coles, an educator and Director of Diversity &amp; Inclusion for the Lower Merion School District. Dr. James-Cole shared her lived experience with MASH and how she manages the ups and downs of her condition while the presenters highlighted practical, sustainable strategies for managing MASH and improving overall health.&nbsp;</p>



<p>In addition to the clinical and nutrition-focused sessions, the Summit featured a “<strong>Meet the Journalists</strong>” panel discussion that offered insights and strategies for working with various media outlets - TV, radio, podcasts, and newspapers. Three well-known Chicago journalists shared their expertise and tips for engaging with journalists - Emmy-winning <a href="https://www.nbcchicago.com/author/regina-waldroup/" rel="nofollow noopener" target="_blank">NBC5 reporter Regina Waldroup</a>, covers health and wellness initiatives, medical advancements, community human-interest stories and charitable events; <a href="https://chicago.suntimes.com/authors/elvia-malagon" rel="nofollow noopener" target="_blank">Chicago Sun Times Health Reporter Elvia Malagón</a>, the recipient of numerous prestigious awards, including Best Community Reporting for her coverage of diversity in Rogers Park, writes articles on social justice issues, income inequality and community-driven human interest stories; and Award-winning veteran journalist <a href="https://www.axios.com/local/chicago/authors/meng" rel="nofollow noopener" target="_blank">Monica Eng of Axios Chicago</a> who has over 30 years of experience in journalism currently covers food, culture, health, politics, and metro news. She also co-hosts, <em>Chewing</em>, a podcast about various food and health topics.&nbsp;&nbsp;</p>



<p>An informative session on <strong>Storytelling and Media Coaching</strong> was led by David Viggiano and Charisse Barnachea of <a href="https://www.mekkymedia.com/" rel="nofollow noopener" target="_blank">Mekky Media</a> where the power of sharing your personal story with the press was emphasized and the importance of sharing your journey to help educate and inspire the public was highlighted throughout the presentation. Participants learned clear, memorable messages and how to frame their story during an interview.</p>



<p>“We are so grateful to the expert panelists who led such powerful and informative presentations for our attendees,” said Ms. Stiehl. “Bringing together patients who are living with MASH or MASLD is an important part of building a stronger, more informed community. We are very grateful to our Presenting Sponsor, Madrigal, and our Silver Sponsor, Boehringer Ingelheim, for providing this important opportunity for patients.”</p>



<p>For more information about ALF, please visit <a href="http://www.liverfoundation.org">www.liverfoundation.org</a>. If you have any questions or concerns regarding <a href="https://liverfoundation.org/liver-diseases/">liver diseases</a>, please call our FREE helpline at 1-800-Go-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/american-liver-foundation-hosts-mash-empower-and-educate-summit/">American Liver Foundation Hosts MASH: Empower and Educate Summit</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ALF Celebrates Five Decades of Impact at 50th Anniversary National Legacy Gala</title>
		<link>https://liverfoundation.org/resource-center/blog/alf-celebrates-five-decades-of-impact-at-50th-anniversary-national-legacy-gala/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 13:21:45 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24538</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF) will commemorate five decades of service to patients and families as well as medical professionals and leading organizations at its 50th Anniversary National Legacy Gala on Wednesday, Oct. 28, at Gotham Hall in New York City.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alf-celebrates-five-decades-of-impact-at-50th-anniversary-national-legacy-gala/">ALF Celebrates Five Decades of Impact at 50th Anniversary National Legacy Gala</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><em>Honoring the Achievements of UPMC, AstraZeneca, Dr. Arun Sanyal and NOVO for transformative contributions to the liver community</em></p>



<p><a href="https://liverfoundation.org">American Liver Foundation (ALF)</a> will commemorate five decades of service to patients and families as well as medical professionals and leading organizations at its <a href="https://alfgala.org/national-legacy-gala/" rel="nofollow noopener" target="_blank">50th Anniversary National Legacy Gala</a> on <strong>Wednesday, Oct. 28</strong>, at Gotham Hall in New York City. ALF will celebrate its legacy through tributes to multiple awardees – <a href="https://alfgala.org/national-legacy-gala/support/#p2p/319063" rel="nofollow noopener" target="_blank">UPMC</a> (Transplant Legacy Award), <a href="https://alfgala.org/national-legacy-gala/support/#AstraZeneca" rel="nofollow noopener" target="_blank">AstraZeneca</a> (Patient Impact Award), <a href="https://alfgala.org/national-legacy-gala/support/#ArunSanyal" rel="nofollow noopener" target="_blank">Arun Sanyal, MD</a>, of Virginia Commonwealth University (Leadership Award), and <a href="https://alfgala.org/national-legacy-gala/support/#Novo" rel="nofollow noopener" target="_blank">NOVO</a> (Leadership Innovation Award). In addition, ALF will present its Leadership Award for Public Service to <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Frank A. Anania, MD,</a> of the Food and Drug Administration (FDA) and <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Jay H. Hoofnagle, MD</a>, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Finally, ALF will award its <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">Distinguished Scientific Achievement Award (DSAA)</a> to <a href="https://sbpdiscovery.org/scientists/michael-karin-phd/" rel="nofollow noopener" target="_blank">Director and Professor Michael Karin, PhD</a>, of the Center for Metabolic and Liver Diseases at Sanford Burnham Prebys Medical Discovery Institute. Each recipient represents a shared commitment to better the lives of liver patients and highlights ALF’s past, present and future accomplishments on behalf of the 100 million Americans living with some form of liver disease.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “As American Liver Foundation celebrates 50 years of impact, our 2026 honorees embody the progress that is possible when clinical excellence, patient-centered partnerships, scientific leadership and bold innovation come together,” said Lorraine Stiehl, CEO of American Liver Foundation and a caregiver for a transplant recipient. “All of our awardees have each helped move the liver community forward in meaningful ways, and we are proud to recognize their achievements as we honor the past, celebrate the present, and look toward the future’s next 50 years to create a world free from liver disease.”</p>



<p><strong>The 2026 Award Recipients include:</strong></p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#p2p/319063" rel="nofollow noopener" target="_blank"><strong>Transplant Legacy Award, UPMC</strong></a><strong><u></u></strong></p>



<p>With nearly 30 years of demonstrated commitment to a shared mission of offering hope and healing to liver patients, <a href="https://www.upmc.com/?utm_mrid=mrid0689&amp;utm_adgroup=85731913810&amp;utm_advertiserid=8542765693&amp;gclid=65eb1157943512c2c0927b94738afdf7&amp;gclsrc=3p.ds&amp;msclkid=65eb1157943512c2c0927b94738afdf7&amp;utm_source=bing&amp;utm_medium=cpc&amp;utm_campaign=System%20-%20Branded%20-%20National&amp;utm_term=www.upmc.com&amp;utm_content=UPMC%20URLs%20-%20Exact" rel="nofollow noopener" target="_blank">UPMC</a> continues to demonstrate both exemplary leadership and continued generosity to ALF initiatives. Having performed more than 20,000 adult and pediatric organ transplant procedures, UPMC continues to advance lifesaving care for patients facing the most complex liver diseases. As the nation’s leading transplant center conducting the highest number of living donor liver transplants in the United States, UMPC has given thousands of patients a second chance at life. Beyond its clinical excellence, UMPC’s longstanding support of ALF has helped drive critical patient education, advocacy, research, and support services to many liver patients. UPMC’s unwavering commitment to advancing liver health for generations to come is a legacy worth celebrating.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#AstraZeneca" rel="nofollow noopener" target="_blank"><strong>Patient Impact Award, AstraZeneca</strong></a><strong></strong></p>



<p><a href="https://www.astrazeneca.com/" rel="nofollow noopener" target="_blank">AstraZeneca</a> will be recognized for its patient-centered efforts to help transform liver disease and liver cancer care through science, partnerships, advocacy and groundbreaking advances in medicine. AstraZeneca’s therapies have addressed some of the world’s most complex health challenges while reaching millions of patients in more than 125 countries. As a global, science-led biopharmaceutical company, AstraZeneca is dedicated to the discovery, development, and commercialization of innovative prescription medicines across Oncology, Rare Diseases, Cardiovascular, Renal &amp; Metabolism, and Respiratory &amp; Immunology. A founding partner of ALF’s transformative <em>Think Liver Think Life</em> public health campaign, the company has played an important role in expanding screening, education, and support resources in diverse communities across the country. Its continuing research and collaboration across stomach and gut cancer care reflects a commitment to addressing unmet needs and improving patient’s experiences.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#ArunSanyal" rel="nofollow noopener" target="_blank"><strong>Leadership Award, Dr. Arun Sanyal</strong></a><strong><u></u></strong></p>



<p>Arun J. Sanyal, MD, is one of the world’s leading experts in liver disease research and has helped shaped the global approach to understanding and treating <a href="https://us-east-2.protection.sophos.com?d=urldefense.com&amp;u=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&amp;i=NjZlOWJlMDlhZWY4NTUwZTY2MmE0Njg2&amp;t=YTdhV3dFYnVoK3VQWm5EYXdGR1VBaCtWRlAzRFlxRTloUGV1aXhsV2hGZz0=&amp;h=323f935e88b6417aba6a5a1c9c1cc6b3&amp;s=AVNPUEhUT0NFTkNSWVBUSVbOnd89rL3xJVz9Op9bY9T44xZTl_I9YxllAWGxbqSJcQ" target="_blank" rel="noreferrer noopener nofollow">metabolic dysfunction associated steatotic liver disease (MASLD)</a> and <a href="https://us-east-2.protection.sophos.com?d=urldefense.com&amp;u=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&amp;i=NjZlOWJlMDlhZWY4NTUwZTY2MmE0Njg2&amp;t=dE1YdnRlMlpkOGJoMW1jMGhIVzNKUU4xcGlBMFl2WUQ0NUVrS0FUeWU5cz0=&amp;h=323f935e88b6417aba6a5a1c9c1cc6b3&amp;s=AVNPUEhUT0NFTkNSWVBUSVbOnd89rL3xJVz9Op9bY9T44xZTl_I9YxllAWGxbqSJcQ" target="_blank" rel="noreferrer noopener nofollow">metabolic dysfunction associated steatohepatitis (MASH)</a>. Dr. Sanyal is the Professor Director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health School of Medicine Internal Medicine at Virginia Commonwealth University. Through internationally recognized research, multidisciplinary collaboration and the development of new therapeutics, Dr. Sanyal has advanced the field and created new possibilities for liver patients and their families. As a pioneering innovator and industry thought leader, he has authored more than 450 scientific publications in leading peer-reviewed journals such as, The New England Journal of Medicine, The Lancet, Nature Medicine, and Gastroenterology. His contributions to science, mentorship, and patient care have been widely recognized throughout the country.</p>



<p><a href="https://alfgala.org/national-legacy-gala/support/#Novo" rel="nofollow noopener" target="_blank"><strong>Leadership Innovation Award, NOVO</strong></a><strong></strong></p>



<p>For over a century, NOVO has specialized in discovering, developing and delivering protein and peptide-based treatments for serious chronic diseases, primarily diabetes and metabolic care, and is being honored for its innovation in metabolic health and liver disease. Building upon decades of expertise in diabetes and obesity, the organization is advancing research in metabolic dysfunction-associated steatohepatitis (MASH), a serious and often silent form of liver disease for which more treatment options are needed. Its scientific programs, educational resources and commitment to translating research into real-world care reflect the forward-looking leadership the award celebrates.</p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additionally, the 2026 ALF Leadership Award for Public Service will be presented to Director of the Division of Hepatology and Nutrition at the U.S. Food and Drug Administration (FDA) <a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Frank A. Anania, MD, FAASLD</a>, who oversees the safety, efficacy, and regulatory review of clinical trials and novel drug pipelines. For the past eight years, his work has been crucial for nonviral liver diseases, including MASH <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">and primary sclerosing cholangitis (PSC)</a>. &nbsp;<a href="https://alfgala.org/national-legacy-gala/leadership-award-for-public-sevice/" rel="nofollow noopener" target="_blank">Jay H. Hoofnagle, MD, FAASLD</a>, Former Director of the Liver Diseases Research Branch of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), will also receive this award that evening. Although he retired this year, his career spans more than 50 years in liver disease research. Dr. Hoofnagle wrote the first National Institutes of Health (NIH) Action Plan for Liver Disease Research that served as guidance and structure for NIH funding.</p>



<p>ALF will also present <a href="https://sbpdiscovery.org/scientists/michael-karin-phd/" rel="nofollow noopener" target="_blank">Director and Professor Michael Karin, PhD.,</a> of the Center for Metabolic and Liver Diseases at Sanford Burnham Prebys Medical Discovery Institute with the foundation’s <a href="https://liverfoundation.org/research/distinguished-scientific-achievement-award/">2026 Distinguished Scientific Achievement Award</a> at a VIP reception preceding the Gala. Dr. Karin is internationally renowned for many career achievements but proving the molecular link between chronic inflammation and cancer is his most notable discovery. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>



<p>The evening will also feature <a href="https://alfgala.org/national-legacy-gala/support/#TommyNolan" rel="nofollow noopener" target="_blank">ALF’s LIVEr Champion Tommy Nolan</a> who lived with liver disease for years while being a U.S. Navy veteran serving from 1978 to 1982 and a NYPD sergeant from 1988 to 2006. During retirement, Tommy began playing with the renown NYPD Pipes and Drums and was completely unaware of a serious liver disease progressing silently. After a routine doctor’s appointment revealed elevated liver enzymes, he was diagnosis with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis (PSC</a><strong>)</strong>, a rare autoimmune liver disease with no cure that had progressed to liver cirrhosis. In 2023, he had a complex liver transplant that saved his life. Through it all, Tommy remained focused on healing and is grateful for the second chance at life he’s been given.</p>



<p>ALF extends its deepest gratitude to the 2026 National Legacy Gala Chair, <a href="https://alfgala.org/national-legacy-gala/support/#SamanthaKellner" rel="nofollow noopener" target="_blank">Samantha Kellner</a>, whose personal connection to ALF’s mission was shaped by the birth of her second child Raphael, diagnosed with a rare liver disease called <a href="https://liverfoundation.org/liver-diseases/pediatric-liver-information-center/pediatric-liver-disease/biliary-atresia/">biliary atresia</a> as an infant and given a lifesaving transplant within eight weeks of his birth. Inspired by their family’s journey, Samantha and her family launched the Kellner Pediatric Liver Foundation (KPLF) and celebrated their 20<sup>th</sup> Anniversary as dedicated advocates for children and families affected by liver disease.</p>



<p>Doors for the National Legacy Gala open at 6 p.m. and the program begins at 6:50 p.m. with a cocktail reception. The evening includes a unique silent auction, a three-course plated dinner, an exciting live auction, and a memorable awards ceremony. Funds raised through the 50<sup>th</sup> Anniversary National Legacy Gala benefit the 100 million Americans affected by liver disease through <a href="https://liverfoundation.org/resource-center/">resources</a>,&nbsp;<a href="https://liverfoundation.org/about-your-liver/">education</a>&nbsp;and&nbsp;<a href="https://liverfoundation.org/resource-center/help-center/">support services</a>&nbsp;and to help&nbsp; advance&nbsp;<a href="https://liverfoundation.org/medical-professionals/research-awards-program/research-program-overview/">research&nbsp;</a>and our patient&nbsp;<a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/">advocacy </a>efforts on Capitol Hill.&nbsp;</p>



<p>Learn more about the Gala at <a href="https://alfgala.org/national-legacy-gala/" target="_blank" rel="noreferrer noopener nofollow">alfgala.org</a> and purchase <a href="https://alfgala.org/national-legacy-gala/sponsorships-tickets/" target="_blank" rel="noreferrer noopener nofollow">sponsorships or tickets</a>. You can also participate in ALF’s silent auction, which is available for pre-event and remote bidding; items include cruises, stays to locations around the world, fun leisure-time experiences, city winery excursions in New York and high-end gifts and accessories. Check back frequently as new items are added daily. View the free live stream and register for GiveSmart at <a href="https://e.givesmart.com/events/Q1b/" target="_blank" rel="noreferrer noopener nofollow">LegacyGala26.givesmart.com</a>.</p>



<p><strong><u>About the American Liver Foundation</u></strong></p>



<p>American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research, and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. Celebrating 50 years of impact, leading the next 50 years forward. For more information, please visit&nbsp;<a href="http://www.liverfoundation.org/">www.liverfoundation.org</a>&nbsp;or call: 1.800.GO.LIVER (800-465-4837).</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alf-celebrates-five-decades-of-impact-at-50th-anniversary-national-legacy-gala/">ALF Celebrates Five Decades of Impact at 50th Anniversary National Legacy Gala</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ALF’s Liver Life Challenge is Official Charity Partner of 2026 Bank of America Chicago Marathon</title>
		<link>https://liverfoundation.org/resource-center/blog/alfs-liver-life-challenge-is-official-charity-partner-of-2026-bank-of-america-chicago-marathon/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Fri, 09 Oct 2026 16:44:06 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24510</guid>

					<description><![CDATA[<p>American Liver Foundation (ALF) is proud to once again be among the more than 200 non-profits participating as a member of the 2026 Bank of America Chicago Marathon Official Charity Program this Sunday, October 11.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alfs-liver-life-challenge-is-official-charity-partner-of-2026-bank-of-america-chicago-marathon/">ALF’s Liver Life Challenge is Official Charity Partner of 2026 Bank of America Chicago Marathon</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.liverfoundation.org">American Liver Foundation (ALF)</a> is proud to once again be among the more than 200 non-profits participating as a member of the&nbsp;2026 <a href="https://liverlifechallenge.org/chicago/" target="_blank" rel="noreferrer noopener nofollow">Bank of America Chicago Marathon Official Charity Program</a> this <strong>Sunday, October 11. </strong>This 26.2-mile elite road race through Chicago is considered one of the fastest marathons in the world and it begins in iconic Grant Park.</p>



<p>“As thousands prepare to run in this single-loop course, ALF is honored to be an official charity partner for the upcoming Bank of America Chicago Marathon once again and to have a dedicated team of runners helping to raise awareness regarding liver disease as they run through the vibrant streets of Chicago,” said Lorraine Stiehl, Chief Executive Officer, American Liver Foundation.</p>



<p>Liver Life Challenge is ALF’s official endurance program where dedicated athletes across the country join Team ALF to use their passion and commitment to go that extra mile in honor of a loved one and on behalf of &nbsp;the liver community. The Chicago Marathon is the ultimate achievement for elite athletes and everyday runners. For ALF, this marathon is not only a celebration of endurance but a powerful platform to <a href="https://liverfoundation.org/liver-diseases/facts-about-liver-disease/what-does-your-liver-do/">educate</a>, <a href="https://liverfoundation.org/resource-center/">engage</a>, and <a href="https://liverfoundation.org/resource-center/patient-empowerment/patient-stories/">inspire</a> as we shine a spotlight on the urgent need for <a href="https://liverfoundation.org/resource-center/videos/liver-disease-liver-cancer-prevention-and-screening/">liver disease prevention</a>, <a href="https://liverfoundation.org/research/research-program-overview/">research,</a> and <a href="https://liverfoundation.org/resource-center/online-support-groups/">patient support</a>.</p>



<p><strong>Nashua, New Hampshire</strong> resident <a href="https://liverlifechallenge.org/chicago/support/#Jim2026" rel="nofollow noopener" target="_blank">Jim O’Connell</a>, is the 2026 ALF Team Captain who runs in honor of his late father. Jim has committed himself to doing something positive in honor of his dad, so he ran the Boston Marathon with ALF for 10 years, and this is his second year running in the Chicago Marathon. Jim said “We lost my dad to liver cancer at far too young an age and it impacted our family greatly as that loss is still felt today. He was an amazing friend to so many, and an even better Dad we still miss very much. I have met so many amazing people through ALF with similar stories to mine, but also people who have lived with liver disease, doctors and nurses who know about liver disease all too well, and even liver transplant recipients who are not only thriving - but have run alongside me!&nbsp;It's all just so inspiring, so continuing to raise money to benefit ALF is deeply important to me.”</p>



<p><strong>Chicago resident </strong><a href="https://liverlifechallenge.org/chicago/support/#sydneyflakus-witte" rel="nofollow noopener" target="_blank"><strong>Sydney Flakus-Witte</strong></a> works in research at the University of Chicago where she explores gut microbiomes and its impact on liver health. She stated: “This is the second year I’m running in the Chicago Marathon in honor of my husband who was diagnosed seven years ago with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis</a>, a rare autoimmune liver condition, that currently has no approved therapies to slow its progression.Watching him navigate this journey is a constant reminder that we need new scientific understandings to address these underlying problems. I am running to help fund the research that will one day provide better answers for families like mine."</p>



<p>ALF’s&nbsp;<a href="https://liverlifechallenge.org/chicago/" target="_blank" rel="noreferrer noopener nofollow">2026 Bank of America Chicago Marathon team</a>&nbsp;is working hard to reach their fundraising goal. All funds raised will go towards ALF’s mission to support those affected by&nbsp;<a href="https://liverfoundation.org/liver-diseases/">liver disease</a>. Team ALF is made up of runners with varying levels of experience from novice to advanced, most of whom have a connection to liver disease.</p>



<p><strong>Other members of ALF’s 43-member team include: &nbsp;</strong></p>



<ul class="wp-block-list">
<li><a href="https://liverlifechallenge.org/chicago/support/#kryandoyen" rel="nofollow noopener" target="_blank">Kathleen Doyen</a>: Running the Chicago Marathon for the 1<sup>st</sup> time in honor of her mother, ALF board member, <a href="https://liverfoundation.org/about-alf/people/anne-chapski-doyen/">Anne Doyen</a>, who is a liver transplant recipient because Kathleen was a match and became her mom’s living liver donor.  </li>



<li><a href="https://liverlifechallenge.org/chicago/support/#mike" rel="nofollow noopener" target="_blank">Michael Doyen</a>: Running for the 3<sup>rd</sup> time in the Chicago Marathon in honor of his wife and ALF board member, Anne Doyen, who is a liver transplant recipient. Their daughter, Kathleen, was her living liver donor.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#MaddieRunsChicago" rel="nofollow noopener" target="_blank">Madelyn Dulin</a>: Running for the 1<sup>st</sup> time in honor of her husband who was diagnosed with <a href="https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/">primary sclerosing cholangitis (PSC)</a> when he was 18. In 2021, while they were both in medical school, he received a liver transplant. Now they are both working as resident physicians where he received his transplant.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#p2p/312514" rel="nofollow noopener" target="_blank">Megan Hoffman</a>:Running for the 1<sup>st </sup>time in honor of her patients and their strength as well as to give back to the liver community that inspires her every day as a liver transplant social worker at The University of Chicago<strong>. </strong>She witnesses the courage it takes to face liver disease, the resilience required to undergo transplant, and the strength it takes to rebuild your life after the transplant.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#alexkerr" rel="nofollow noopener" target="_blank">Alex Kerr</a>, Running the Chicago Marathon for  the 1<sup>st</sup> time to honor his father who was diagnosed with a rare liver disease. He is also a new ALF board member.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#AmandaNeal" rel="nofollow noopener" target="_blank">Amanda Neal</a>: Running for the 1<sup>st</sup> time in honor of a child named Beckett who she donated a part of her liver to as a living liver donor. She said It was the most meaningful decision of her life and it changed how she thinks about health, generosity, and the power of people rallying together to save a life.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#marinasilveira" rel="nofollow noopener" target="_blank">Marina Silveira, MD</a>: Running for the 1<sup>st</sup> time to honor all of her patients living with liver disease. She is a  hepatologist with a special interest in autoimmune and cholestatic liver diseases at the Yale School of Medicine.</li>



<li><a href="https://liverlifechallenge.org/chicago/support/#awhiteaker" rel="nofollow noopener" target="_blank">Alex Whiteaker</a>: Running in memory of his father and for all the miles he can no longer put under his feet as he passed away in 2007 while waiting for a second transplant. After receiving his first transplant in 1996, Alex's dad dedicated his new life to fitness and bettering himself every day. Alex's dad went on to run the NYC Marathon twice and competed in many World Transplant Games.</li>
</ul>



<p>Learn more about ALF’s 2026 Bank of America Chicago Marathon team at <a href="https://liverlifechallenge.org/chicago/" rel="nofollow noopener" target="_blank">Home - Bank of America Chicago Marathon 2026</a>.</p>



<p><strong><u>About the American Liver Foundation</u></strong></p>



<p>American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research, and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. Celebrating 50 years of impact, leading the next 50 years forward. For more information, please visit&nbsp;<a href="http://www.liverfoundation.org/">www.liverfoundation.org</a>&nbsp;or call: 1.800.GO.LIVER (800-465-4837).</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alfs-liver-life-challenge-is-official-charity-partner-of-2026-bank-of-america-chicago-marathon/">ALF’s Liver Life Challenge is Official Charity Partner of 2026 Bank of America Chicago Marathon</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Weekly Healthcare Policy Round-Up</title>
		<link>https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-44/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 12:22:51 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24493</guid>

					<description><![CDATA[<p>A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-44/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong>In this week’s Health Policy Round-Up, ALF shares the most up to date news happening in Washington DC.</strong></p>



<ul class="wp-block-list">
<li>Members of the House and Senate have departed Washington, D.C., for the campaign-season recess and are now back in their home states until after the election on November 3<sup>rd</sup>.</li>



<li>This week the Senate Health, Education, Labor and Pensions Committee voted to advance the nomination of Dr. Nicole Saphier for surgeon general. Dr. Saphier served as the director of breast imaging at Memorial Sloan Kettering Monmouth in New Jersey. Dr. Saphier earned her medical degree from Ross University School of Medicine in Barbados and completed a fellowship at the Mayo Clinic. A Senate confirmation vote has not been scheduled at this time. ALF will continue to monitor for updates.</li>



<li>October is National Liver Awareness Month and Liver Cancer Month, and now is the time to make liver health a national priority. More than 100 million Americans are affected by some form of liver disease. By taking action, you can send a message directly to your members of Congress urging them to support these critical policies. Take action <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/take-action/?vvsrc=%2fCampaigns%2f133344%2fRespond">here!</a></li>
</ul>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-44/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ALF Honors National Liver Awareness &#038; Liver Cancer Month</title>
		<link>https://liverfoundation.org/resource-center/blog/alf-honors-national-liver-awareness-liver-cancer-month/</link>
		
		<dc:creator><![CDATA[William Rivera]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 20:50:15 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24477</guid>

					<description><![CDATA[<p>An estimated 80 to 100 million Americans have liver disease, but many don’t know it because early symptoms can be subtle. October is National Liver Awareness Month and Liver Cancer Month and ALF is raising awareness and connecting people with vital resources. Take ALF’s one-minute quiz to understand your risk for liver disease, liver cancer or both.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alf-honors-national-liver-awareness-liver-cancer-month/">ALF Honors National Liver Awareness &amp; Liver Cancer Month</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="text--l text--primary">Take ALF’s Liver Health Quiz, Learn About Living Donor Liver Transplant, Try a Liver Healthy Recipe, and Advocate for Liver Health</p>



<p>An estimated 80 to 100 million Americans have liver disease, but many don’t know it because early symptoms can be subtle. October is <strong>National Liver Awareness Month</strong> and <strong>Liver Cancer Month</strong> and <a href="https://liverfoundation.org">American Liver Foundation (ALF)</a> is raising awareness and connecting people with vital resources. Take <a href="https://thinkliverthinklife.org/liver-health-quiz/" rel="nofollow noopener" target="_blank">ALF’s one-minute quiz</a> to understand your risk for liver disease, liver cancer or both. Learn more about living donor liver transplant by visiting ALF’s <a href="https://livingdonornetwork.liverfoundation.org/?_gl=1%2A1gj9bej%2A_ga%2AMTA4NTIyNDA4Ni4xNzQ2ODE5MDAz%2A_ga_2ZKK0NTX5Y%2AczE3ODkxNDk1NjMkbzYzMyRnMSR0MTc4OTE0OTc4MiRqNTEkbDAkaDA.">Living Donor Network™ website</a> or watch our <a href="https://www.youtube.com/watch?v=HoH-pn65ArQ" rel="nofollow noopener" target="_blank">short-animated video</a> and share it on your social channels. Try one of ALF’s recipes in our <a href="https://liverfoundation.org/health-and-wellness/healthy-lifestyle/recipes/">30-day Liver Healthy Meal Plan</a> and view <strong>20 new</strong> <a href="https://www.youtube.com/playlist?list=PLHvqSsrH2mL4" rel="nofollow noopener" target="_blank">recipe videos</a>. <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/take-action/?vvsrc=%2fCampaigns%2f139896%2fRespond">Advocate for legislation</a> that can improve the lives of people affected by liver disease and participate in <a href="https://liverfoundation.org/events/">free educational and community events</a> held throughout the month.</p>



<p>“October’s observance of National Liver Awareness Month and Liver Cancer Awareness Month is a vital opportunity to remind everyone that liver health deserves year-round attention,” said Lorraine Stiehl, CEO of American Liver Foundation and a caregiver for a transplant recipient.&nbsp; “By increasing awareness of risk factors, encouraging timely screenings and early detection through ALF’s quick liver health quiz, sharing ALF’s 30-day Liver Healthy Meal Plan, and connecting patients and families with trusted information and support, we can all help save lives and move closer to a future free from liver disease.”</p>



<p><strong>Take the Quiz!</strong></p>



<ul class="wp-block-list">
<li>Through ALF’s simple <a href="https://thinkliverthinklife.org/liver-health-quiz/" rel="nofollow noopener" target="_blank"><strong>liver health quiz</strong></a>, available in English at <a href="https://thinkliverthinklife.org/liver-health-quiz/" rel="nofollow noopener" target="_blank"><strong>thinkliverthinklife.org/quiz</strong></a> and in Spanish at <a href="https://thinkliverthinklife.org/prueba/" rel="nofollow noopener" target="_blank"><strong>thinkliverthinklife.org/prueba</strong></a> anyone can find out if they’re at risk for liver disease and liver cancer. <a href="https://liverfoundation.org/liver-diseases/cancer/hepatocellular-carcinoma/"><strong>Hepatocellular Carcinoma (liver cancer)</strong></a> is one of the most rapidly growing causes of cancer-related deaths in the U.S. with incidence rates that have more than tripled since 1980 and death rates doubled during that same time. Learn more about ALF’s <a href="https://thinkliverthinklife.org/" rel="nofollow noopener" target="_blank"><strong>thinkliverthinklife.org</strong></a>, a nationwide public health initiative raising awareness and screening U.S. adults for liver disease.</li>
</ul>



<p><strong>Try the Recipes!&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p>



<ul class="wp-block-list">
<li><a>Through ALF’s </a><a href="https://liverfoundation.org/health-and-wellness/healthy-lifestyle/recipes/"><strong>30-day Liver Healthy Meal Plan,</strong></a> anyone can learn what to eat to help take care of their liver. The recipes are easy to make, simple to understand, and do not require complex ingredients. You can also watch<strong>&nbsp;20 new </strong><a href="https://alf.social/RecipeVids" target="_blank" rel="noreferrer noopener nofollow"><strong>recipe videos</strong></a>&nbsp;for&nbsp;additional&nbsp;inspiration. </li>
</ul>



<p><strong>Advocate with Us!</strong></p>



<ul class="wp-block-list">
<li>Throughout October, we’re asking the liver community to elevate the voices of millions of Americans affected by liver disease by sending messages to Members of&nbsp; Congress and asking them to advance policies that can improve their lives. ALF advocates are working to protect and support living organ donors, improve access to treatment, advance early detection of pediatric liver cancer, strengthen federal liver disease prevention and surveillance efforts, and increase investment in liver disease research. Join us and <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/take-action/?vvsrc=%2fCampaigns%2f139896%2fRespond"><strong>Take Action</strong></a>.</li>
</ul>



<p><strong>Join ALF Support Services, Participate in ALF Special Events and Learn more about ALF Programming!</strong></p>



<ul class="wp-block-list">
<li>Join one of American Liver Foundation’s online support groups for caregivers, patients, and transplant recipients! <a href="https://liverfoundation.org/events/sharing-the-journey-an-alf-support-network-for-caregivers-2/2026-10-01/"><strong>Sharing the Journey, an ALF support network for caregivers - American Liver Foundation</strong></a><strong>; </strong><a href="https://liverfoundation.org/events/sharing-the-journey-an-alf-support-network-for-patients-3/2026-10-08/"><strong>Sharing the Journey, an ALF support network for patients - American Liver Foundation</strong></a>; or<a href="https://liverfoundation.org/events/sharing-the-journey-an-alf-support-network-for-liver-transplant-recipients-2/2026-10-15/"><strong>Sharing the Journey, an ALF support network for liver transplant recipients</strong></a>. All sessions are facilitated by a licensed social worker. You must be aged 18 or older to participate. There is no fee to join.</li>



<li>Join <a href="https://liverlifewalk.org/virtualwalk/" rel="nofollow noopener" target="_blank"><strong>Liver Life Walk, Your Way</strong></a> and walk any day, anywhere, your way! Register today at <a href="https://liverlifewalk.org/virtualwalk/" rel="nofollow noopener" target="_blank"><strong>liverlifewalk.org/virtualwalk</strong></a>.</li>



<li>Learn more about <a href="https://livingdonornetwork.liverfoundation.org/?_gl=1%2A1gj9bej%2A_ga%2AMTA4NTIyNDA4Ni4xNzQ2ODE5MDAz%2A_ga_2ZKK0NTX5Y%2AczE3ODkxNDk1NjMkbzYzMyRnMSR0MTc4OTE0OTc4MiRqNTEkbDAkaDA."><strong>ALF’s Living Donor Network™</strong></a><strong> </strong>that connects non-directed (anonymous) living liver donors with transplant centers nationwide, helping more people have access to a lifesaving liver transplant. To learn more about the Network, please watch ALF’s <a href="https://www.youtube.com/watch?v=HoH-pn65ArQ" rel="nofollow noopener" target="_blank"><strong>short-animated video</strong></a><strong>.</strong></li>



<li><strong>October 14 (virtual workshop)</strong> – &nbsp;On HRS Awareness Day, watch our on-demand webinar on ALF’s social media channels, <a href="https://liverfoundation.org/liver-diseases/complications-of-liver-disease/hepatorenal-syndrome/"><strong>HRS-AKI Explained: What It Means for Patients</strong></a>, as Justin Boike, MD, from Northwestern Medicine, provides an overview of hepatorenal syndrome – acute kidney injury (HRS-AKI) from a patient-centered perspective. Topics include what HRS-AKI is, what a diagnosis can mean for patients’ long-term, signs and risk factors patients should be aware of, and how to ask questions and advocate for themselves throughout their liver disease journey. This workshop is sponsored by Keenova.</li>
</ul>



<ul class="wp-block-list">
<li><a href="https://liverfoundation.org/"><strong>American Liver Foundation</strong></a> will host a two-day <strong>MASH Empower &amp; Educate Summit</strong> on <strong>Friday and Saturday, Oct. 16 and 17</strong> aimed at empowering MASH patients and caregivers through education, storytelling, and media training. The Summit seeks to amplify patient voices and raise national awareness of liver disease. Follow ALF’s socials to see exciting updates from the event. </li>



<li>Knowledge is power so empower yourself throughout your liver journey by viewing ALF’s new <a href="https://liverfoundation.org/resource-center/patient-empowerment/patient-empowerment/"><strong>Patient Empowerment Resource Center</strong></a><strong> </strong>filled with in-depth information on liver disease and watch this short <a href="https://youtu.be/uNOFzrCwo1o" rel="nofollow noopener" target="_blank"><strong>video</strong></a> to learn more about maintaining optimal liver health.</li>



<li><strong>Join us on October 28th at 6:50PM ET </strong>for ALF’s<a href="https://alfgala.org/national-legacy-gala/" rel="nofollow noopener" target="_blank"><strong>50<sup>th</sup> Anniversary National Legacy Gala</strong></a><strong> </strong>held at Gotham Hall in New York City. We’ll celebratethe achievements of distinguished leaders and visionaries who have made significant contributions in the liver community. Participate in ALF’s silent auction and view the free live stream, <a href="https://e.givesmart.com/events/Q1b/" rel="nofollow noopener" target="_blank"><strong>LegacyGala26.givesmart.com</strong></a>. Purchase <a href="https://alfgala.org/national-legacy-gala/sponsorships-tickets/" rel="nofollow noopener" target="_blank"><strong>sponsorships or tickets</strong></a> and learn more about the Gala at <a href="https://alfgala.org/national-legacy-gala/" rel="nofollow noopener" target="_blank"><strong>alfgala.org</strong></a>. </li>
</ul>



<p><strong>ALF also offers Free Education for Healthcare Professionals!</strong></p>



<ul class="wp-block-list">
<li><strong>October 1 (virtual workshop) – Critical Care Roundtable: Advancing Multidisciplinary Care in End-Stage Liver Disease.</strong> This roundtable will bring together clinical leaders for a focused discussion on advancing multidisciplinary care for patients with End-Stage Liver Disease. Real-world challenges will be explored with opportunities to strengthen collaboration, care coordination, communication, and patient-centered decision-making across the liver disease continuum. These insights will help inform future educational initiatives and resources to support improved care for patients and families. This critical care initiative is sponsored by Keenova.</li>



<li><strong>October 6 - (virtual CME Program) - </strong><a href="https://iecho.org/hub-profile/ORG1705518959425NPL1AUQS3Q" target="_blank" rel="noreferrer noopener nofollow"><strong>Liver Health Echo Program - Cracking the MASLD Risk Code: Detecting Early Risk Signals to Guide Timely Intervention</strong>.</a> This noon to 1 p.m. virtual community practice equips healthcare providers with the necessary skills to treat and prevent MASLD among their patients.&nbsp;The program includes five one-hour sessions starting in October until February 2027. Register <a href="https://iecho.org/welcome" rel="nofollow noopener" target="_blank">here.</a></li>



<li><strong>October 23 (virtual workshop) - Addressing Fatigue in Liver Diseases – From Unmet Needs to Action. </strong>This workshop will help develop a focused, fundable roadmap to improve understanding, assessment, and management of fatigue in liver diseases. This virtual workshop will include clinicians/researchers who are experts in liver diseases, fatigue measurement and patient-reported outcomes experts, and cross-disease fatigue. This virtual workshop is sponsored by Ipsen and ALFASIGMA.</li>
</ul>



<p>American Liver Foundation gratefully acknowledges our <a href="https://thinkliverthinklife.org/" rel="nofollow noopener" target="_blank"><strong>Think Liver Think Life®</strong></a><strong> </strong>Premier Sponsor, <a>Astra Zeneca</a>, for their continued leadership and support in helping us reach those most in need in underserved communities. ALF also expresses gratitude to the following additional Think Liver Think Life campaign sponsors that support our impactful educational and awareness resources which help patients, families and healthcare professionals nationwide: Boehringer Ingelheim, Genentech, Gilead, Ipsen, Keenova, Madrigal, Merck and My Fitness Pal.</p>



<p>For more information about ALF, please visit <a href="http://www.liverfoundation.org"><strong>www.liverfoundation.org</strong></a>. If you have any questions or concerns regarding liver disease, please call our FREE helpline at 1-800-GO-LIVER (800-465-4837) Monday through Friday from 9 a.m. to 5 p.m. ET.</p>
<p class="last-updated margin-top--m text--italic">Last updated on October 2nd, 2026 at 11:55 am</p><p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/alf-honors-national-liver-awareness-liver-cancer-month/">ALF Honors National Liver Awareness &amp; Liver Cancer Month</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Weekly Healthcare Policy Round-Up</title>
		<link>https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-43/</link>
		
		<dc:creator><![CDATA[Christian Velez]]></dc:creator>
		<pubDate>Fri, 04 Sep 2026 13:09:16 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<guid isPermaLink="false">https://liverfoundation.org/?p=24305</guid>

					<description><![CDATA[<p>A lot is happening in Washington DC, so the ALF team will draft a weekly health policy round-up to keep you up to date and informed.</p>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-43/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong>In this week’s Health Policy Round-Up, ALF shares the most up to date news happening in Washington DC.</strong></p>



<ul class="wp-block-list">
<li>This week, the House of Representatives returned from their August recess and approved a continuing resolution (CR) to keep the federal government funded through December 11, avoiding a potential government shutdown in October. The Senate had already passed the CR in early August.</li>



<li>September is Childhood Cancer Awareness Month. Too often, children are diagnosed late, limiting treatment options and leading to devastating outcomes for families. Please take action and ask Congress to support the Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act (H.R. 5355). <a href="https://liverfoundation.org/how-you-can-help/get-involved/advocate/take-action/">Take action here</a>.</li>



<li>Last month President Trump nominated Dr. Heidi Overton to become the next Commissioner of the Food and Drug Administration. Dr. Overton currently serves as the Deputy Director of the White House Domestic Policy Council. Dr. Overton attended medical school at the University of New Mexico. She trained as a general surgery resident at Johns Hopkins. Prior to joining Trump's second administration, she was the chief policy officer at the America First Policy Institute. Dr. Overton will need to be confirmed by the Senate, but no hearing date has been set.</li>



<li>The House of Representatives will return to their district for the week of Labor Day. Both the House and Senate are expected to return to Washington, D.C. the week of September 14<sup>th</sup>.</li>
</ul>
<p>The post <a rel="nofollow" href="https://liverfoundation.org/resource-center/blog/weekly-healthcare-policy-round-up-43/">Weekly Healthcare Policy Round-Up</a> appeared first on <a rel="nofollow" href="https://liverfoundation.org">American Liver Foundation</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
